Previous genome-wide association studies (GWAS) in populations of European descent identified a lung cancer susceptibility locus at 15q25 that was biologically associated with nicotine addiction. However, the allele frequency of susceptibility variants identified in this region varied dramatically across European and Asian populations, suggesting that additional risk single nucleotide polymorphism (SNPs) in Asians need to be identified. Thus, we conducted a fine-mapping study of chromosome 15q25 using targeted resequencing of 200 lung cancer cases and 300 controls of Chinese descent. An approximate conditional and joint analysis of the discovery data revealed two novel SNPs with independent effects (rs6495304: OR = 1.79, P = 9.37 × 10 −4 ; and rs74733525: OR = 1.68, P = 8.05 × 10 −3
Introduction
Lung cancer is the leading cause of cancer-related deaths in the world, with more than one million deaths annually (1) . In 2015, estimated annual lung cancer deaths in China had increased to 610 200 (2) . Smoking is the major risk factor for lung cancer, relating to approximately 90% of lung cancer cases (3) . As the world's leading tobacco producing and consuming country, China is home to one-third of all smokers globally. In 2010, it was estimated that there were 301 million current smokers in China and that 85.6% of them smoked daily (4) . Although new, efficacious techniques for smoking cessation have helped to reduce the number of smokers significantly, less than 5% succeed. Of these smokers, approximately 60% are addicted to nicotine (5) .
Many aspects of cigarette-smoking behavior cluster in families (6) . Evidence from twin and family studies revealed that genetic factors are important to the etiology of nicotine dependence, with an estimated heritability of 0.56 (7) . The risk of developing nicotine dependence for the sibling of a nicotinedependent individual is twice that of the general population (6) .
A cluster of three genes, CHRNA5, CHRNA3 and CHRNB4 on chromosome 15q25 encode neuronal nicotinic acetylcholine receptor subunits (nAChRs). nAChRs belong to the super family of ligand-gated ion channels that can mediate fast signal transmission at synapses and modulate the release of several neurotransmitters. They are also the initial physiological targets of nicotine in the central and peripheral nervous system. Within a few seconds of smoking, nicotine is delivered to the synapses where these receptors are expressed to initiate nicotine addiction (8) . Consistent with an important role for nAChRs in regulating nicotine intake, knockdown of α5 nAChR subunits in the brain region in rats decreased their sensitivity to rewardinhibiting actions compared with that of control rats (9) .
Recent genome-wide association studies (GWASs) (10) (11) (12) in Caucasian populations identified three single nucleotide polymorphism (SNPs) (rs8034191, rs1051730 and rs16969968) at this locus that were associated with lung cancer risk. It was suggested that these SNPs might exert their effects on lung cancer through a nicotine-related pathway. However, it is worth noting that the allelic frequencies of the variants identified were low in Asians (minor allele frequency, MAF < 0.05), and no association was found in relation to smoking behaviors or lung cancer risk in Chinese populations (13) . Our previous work identified four novel genetic variants at this locus using haplotype-tagging strategy (13) , but may have missed variants outside the selected linkage disequilibrium (LD) block. Targeted resequencing, which is frequently used in fine-mapping studies, can provide a comprehensive association map (14) (15) (16) .
In this study, we aimed to identify novel genetic variations at 15q25 associated with lung cancer risk in the Han Chinese population. We conducted a two-stage fine-mapping study, which consisted of a discovery cohort with 200 lung cancer cases and 300 controls and an in silico validation cohort with 8047 cases and 8898 controls.
Materials and methods

Study subjects
We performed a two-stage case-control analysis. It was approved by the Institutional Review Board of Nanjing Medical University. Informed consent was obtained from each subject at recruitment. In the discovery stage, 200 lung cancer cases and 300 controls were identified for targeted resequencing; these individuals were also included in our previous GWAS data (17, 18) . Cases were defined as newly diagnosed lung cancer patients and consecutively recruited from the Cancer Hospital of Jiangsu Province and the First Affiliated Hospital of Nanjing Medical University beginning in 2003. Controls were randomly selected from a community-based screening program for noninfectious disease conducted in Jiangsu Province during the same period when the cases were recruited. Lung cancer patients who had a history of cancer, metastasized cancer from other organs, radiotherapy or chemotherapy were excluded. Controls were frequency-matched to the cases for age (±5 years) and sex. All subjects were genetically unrelated and of Han Chinese descent. Participants were face-to-face interviewed by trained interviewers to collect information on demographic data and provided an approximately 5 ml venous blood sample. Individuals were defined as smokers if they had smoked an average of one cigarette or more per day for at least 1 year in their lifetime; otherwise, they were defined as nonsmokers.
In the replication stage, samples were obtained from our published NJMU GWAS data (Nanjing Medical University GWAS from Nanjing and Beijing: 2331 cases and 3077 controls) (17, 18) and NCI GWASs (the National Cancer Institute GWASs: 5716 cases and 5821 controls) (19) . Detailed information about the subjects involved in this study is shown (see Supplementary  Table 1 , available at Carcinogenesis Online). NCI GWASs obtained via the database of Genotypes and Phenotypes (dbGAP) included samples from four studies: (i) the Environment and Genetics in Lung Cancer Etiology (EAGLE) study; (ii) the AlphaTocopherol, Beta-Carotene Cancer Prevention Study (ATBC); (iii) the Cancer Prevention Study II Nutrition Cohort (CPSII) and (iv) the Prostate, Lung, Colon, Ovary Screening Trial (PLCO) (19) . We obtained EAGLE study data from dbGaP phs000093.v2.p2, which included 1945 cases and 1992 controls (SLD) and the other three studies data from dbGaP phs000336.v1.p1, which included 3782 cases and 3840 controls (CADM). Replication stage analyses were conducted separately with subsequent meta-analysis.
Quality control and imputation of GWAS data sets
The NJMU GWAS contained 2331 cases and 3077 controls was conducted using an Affymetrix Genome-Wide Human SNP Array 6.0 with standard quality control procedures described in previous papers (17, 18) . Although the NCI GWASs from dbGaP were not deposited until after the initial quality control, we performed standard quality control on the data. We excluded individuals with low call rates (95%), familial relationships and extreme heterozygosity rates and SNPs with low call rates (95%), MAFs < 0.05 and P < 1 × 10 -6 for the Hardy-Weinberg equilibrium. As a result, 1937 cases and 1984 controls from SLD and 3779 cases and 3837 controls from CADM remained. To facilitate further analysis, the genotyping data were imputed using data from the 1000 Genomes Project (the Phase III integrated variant set release, across 2504 samples) as a reference. We phased the haplotypes with Shapeit v2 (http://www.shapeit.fr/,Phasing step) and performed imputations with IMPUTE2 (http://mathgen.stats.ox.ac.uk/impute/impute_v2.html). Poorly imputed SNPs, defined by an information measure (Is) < 0.40, were further excluded from the analysis.
Targeted re-sequencing and genotyping
We explored the LD structure around the SNP rs1051730, as reported by GWASs (10) (11) (12) , using the HapMap Project database (phase II + III Feb 09, on NCBI B36 assembly, db SNP126). We identified an LD block spanning from chr15:78800300 to chr15:78983700 (hg19) in our study. In total, 210 probes (total size: 183 kb; coverage: 76.19%) were designed using Agilent SureSelect software (http://earray.chem.agilent.com/eArray). Genomic DNA was captured according to the standard Agilent SureSelect protocol (Agilent Technologies, Santa Clara, CA, USA), and associated captured libraries were sequenced on the Genome Analyzer IIx (Illumina, San Diego, CA, USA) (20) . After
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genome-wide association studies MAF minor allele frequency nAChR nicotinic acetylcholine receptor subunit SNP single nucleotide polymorphism removing reads containing sequencing adapters and low-quality reads using the FASTQ Quality Filter tool, high-quality reads were aligned to the human reference genome version hg19 using Burrows-Wheeler Aligner (BWA, V.0.5.9) (http://bio-bwa. source-forge.net) (21) . Picard Tools (http://picard.sourceforge. net/) was used to mark duplicates, and base quality scores were recalibrated using the Genome Analysis Toolkit (GATK, v1.0.5974) from the Broad Institute (22) . Finally, variant calling was performed through GATK and Freebayes (23), and only variants identified by both tools were considered. For quality control, we excluded 8 affected subjects and 22 control subjects because they (i) had a concordance rate <90% as determined by comparing genotypes against existing GWAS genotypes or (ii) yielded a read depth <10× across samples. A total of 1385 variants were detected through targeted resequencing; of these, 1016 were excluded from subsequent analyses for the following reasons: (i) call rate of genotype < 90%; (ii) P value for Hardy-Weinberg equilibrium < 1 × 10 -4 in case, control or all subjects; (iii) MAF < 0.05 (control); (iv) concordance rate < 90% with the previous GWAS for overlapping variants; or (v) absence from the 1000 Genomes Project (www.1000genomes.org) (QC details in Supplementary Figure 1 , available at Carcinogenesis Online). Finally, 369 common SNPs in 192 affected subjects and 278 controls were retained for further association analysis.
Association analysis of variants with lung cancer risk
In the discovery stage, associations between each variant and lung cancer risk were calculated using logistic regression models with adjustment for age, sex and smoking status in PLINK 1.90. Regional plots were created using LocusZoom (24) . An approximate conditional and joint analysis approach using genome-wide complex trait analysis (GCTA: Online Methods) was performed to select index variants in a specific region (25) and those with nominal evidence of association (P < 0.05) were selected for validation. In the validation stage, association analyses of the SNPs identified were performed using SNPTEST v2.5 under a probabilistic dosage model with adjustment for age, sex, pack-years and the first principal component (PC) in NJMU GWAS; age, sex, smoking status and the first PC in SLD GWAS; and age, sex and the first PC in CADM GWAS. Finally, fixed-effect meta-analysis was conducted to assess the pooled genetic effects. Cochran's Q statistic and I2 were calculated using STATA software (V.8.0, College Station, TX, USA). General analyses were performed with R software (V.3.1.1; The R Foundation for Statistical Computing).
Association of SNPs with smoking behavior
Principal component analysis is a useful tool to search for important characteristics among correlated variables. Principal component analysis was performed using the R prcomp function with standard parameters (26) . It allows the identification of latent variables [principal components (PCs)] in the data based on observed variables (in our study, four parameters: packyears, cigarettes per day, smoking duration and smoking status). A Wilcoxon test was used to assess the impact of variants on smoking phenotypes such as pack-years, cigarettes per day, smoking duration and the top PC.
Mediation analysis
We implemented the Baron and Kenny approach for mediation analysis (27) to assess whether smoking behavior mediated the effect of SNP on lung cancer risk, and adapted this approach to address the case-control design by fitting the mediator model only among controls (28) . PC was used as a measure of smoking behavior. For each SNP, the mediation analyses were based on the following three regression models (Equations 1-3). All the models were adjusted for covariates of age and sex.
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Here, X, M and Y denote the genetic variants, smoking behavior and lung cancer, respectively. The terms i 1 -i 3 represent the error terms for each equation, and e 1 -e 3 represent coefficients of covariates. In these equations, the indirect effect a , denoted as a, was the linear regression coefficient of the mediator on an SNP. The total effect, denoted as c, was the logistic regression coefficient of lung cancer on the SNP without considering the mediator. The indirect effect b , denoted as b, was the logistic regression coefficient of lung cancer on the mediator when considering the SNP and the direct effect, denoted as c′, was the logistic regression coefficient of lung cancer on the SNP when considering the mediator. The product of indirect effect a and indirect effect b was termed the indirect effect. Bootstrapping was used to evaluate the significance of the indirect effect based on a resample-based method with replacement (29, 30) . The proportion mediated by smoking behavior is given by the ratio between the indirect effect and the total effect.
Explained variance
Variants identified in our current analysis and those reported in previous studies at this locus were used to calculate the respective variances by assuming the prevalence of lung cancer to be 0.06% (1). We obtained R o 2 from a linear regression and then transformed R o 2 to R 1 2 on the liability scale by using R code described previously (31) .
Functional element analysis and gene expression analysis
The novel SNPs were investigated for the presence of chromatin histone marks and hypersensitive DNAse elements using data from ENCODE included in HaploReg v4.1 (http://www.broadinstitute.org/mammals/haploreg/haploreg.php) and the UCSC genome browser (https://genome.ucsc.edu/cgi-bin/hgGateway).
The results and boxplots of the expression quantitative trait loci analysis in the key regions of brain from the genotype-tissue expression (GTEx) project were obtained from the GTEx Portal (http://www.gtexportal.org/).
Results
Identification of new lung cancer susceptibility SNPs
We found several significant signals at 15q25 (see Supplementary  Figure 2A , available at Carcinogenesis Online). Through approximate conditioning with GCTA, we identified two novel independent SNPs significantly associated with lung cancer risk (Table 1) : rs6495304 (OR = 1.79, 95% CI: 1.27-2.50, P = 9.37 × 10 -4 ) in the intron of AGPHD1 and rs74733525 (OR = 1.68, 95% CI: 1.14-2.46, P = 8.05 × 10 -3 ) in the intron of CHRNA3. Based on LD analysis (Supplementary Figure 2B , available at Carcinogenesis Online), we found that rs6495304 and rs74733525 were not located in the previously reported haplotypes (r 2 < 0.20) (Supplementary  Table 2 , available at Carcinogenesis Online).
Ten genetic variants have been identified by previous studies and association analyses between these variants and lung cancer risk were demonstrated (Supplementary Table 3 , available at Carcinogenesis Online). The directions of effects between four SNPs (rs1051730 and rs8042374 at CHRNA3, rs8034191 at AGPHD1 and rs16969968 at CHRNA5) and lung cancer risk were consistent with previous reports, and effect sizes were essentially identical, suggesting our results were reliable. We also confirmed that the other four SNPs (rs938682 and rs12910984 at CHRNA3, rs2036534 at AGPHD1 and rs667282 at CHRNA5) were associated with lung cancer risk. Besides, rs12914385 and rs6495309 were excluded due to failing in probe design.
In silico validation of rs6495304 and rs74733525
We further validated the associations between the rs6495304 and rs74733525 genetic variants and lung cancer risk using in silico data from multiple lung cancer GWASs conducted in Asian and European populations. In Asian GWAS subjects, both SNPs were associated with increased odds of lung cancer (rs6495304: OR = 1. , Table 1 ). In Caucasian GWAS subjects, rs6495304 demonstrated a weaker significance (OR = 1.24, 95% CI: 1.06-1.46, P = 6.27 × 10 −3 ), with the minor allele of rs6495304 occurring at a much lower frequency; and rs74733525 was monomorphic (Table 1) . We further queried the associations within never-smoking women in Asia (32) ; within this population, these variants did not show any significance (data not shown).
Stratification analyses were performed by using only NJMU GWAS data because both SNPs were rare or monomorphic in European populations. We observed that the risk associated with rs6495304 was significantly different between the subgroups by gender and smoking status (test for heterogeneity, P = 2.00 × 10 −3 and 4.30 × 10 −3 , respectively), but not the subgroups by histology for either variant (P = 0.50 and 0.89, Table 2 ). However, we still found that rs6495304 was significantly associated with different subtypes of non-small cell lung cancer and rs74733525 was only significantly associated with adenocarcinoma, further confirming that these variants in the CHRN genes have different effects in different subtypes of lung cancer.
Potential regulatory mechanisms underlying the association between rs6495304 and smoking behavior
To explore the potential mechanism of the associations, we annotated newly identified variants using HaploReg (33) . We found that rs6495304 was located in DNase I hypersensitivity site (DHS) in 12 different cell lines and an enhancer element marked by an H3K4Me1 signal (Supplementary Table 6 and Supplementary Figure 4A , available at Carcinogenesis Online). In addition, the regulatory motif prediction models based on the position weight matrices indicated that compared to the reference allele, the alternate allele of rs6495304 decreased the affinity of POU class 2 homeobox 2 (POU2F2) (Supplementary Figure 4B , available at Carcinogenesis Online), a common transcription factor binding site in immunoglobulin gene promoters. Further expression quantitative trait loci annotation suggested that the A allele of rs6495304 was associated with the decreased expression of CHRNA3 in the hypothalamus (P = 0.029, Supplementary Figure 4C , available at Carcinogenesis Online).
Single-SNP association with smoking behavior
In addition, a significant multiplicative interaction was observed between rs6495304 and smoking behavior (P = 0.004, Table 3 ). We further repeated the interaction analysis with smoking using the pooled SLD and NJMU GWAS data sets, and obtained similar but more pronounced statistically significance (P = 1.59 × 10 −6 , Supplementary Table 4 , available at Carcinogenesis Online). We next examined the association between rs6495304 and smoking behavior in all 5408 subjects. The frequency of the A allele was higher in heavier smokers and subjects with longer smoking duration (consume > 48 pack-years, >25 cigarettes per day, PC > 35 and smoke > 40 years, Table 4 ). Further analysis suggested that carriers of A allele (adverse) in control subjects who were current smokers (n = 1083) were more likely to be heavy smokers (packyears: P = 0.043, smoking duration: P = 0.007, and PC: P = 0.028) (Supplementary Figure 3 , available at Carcinogenesis Online).
Mediation analysis
To provide further evidence that smoking behavior was a mediator of the association between rs6495304 and lung cancer, we Derived from the fixed effect meta-analysis of the NCI studies (the EAGLE, ATBC, CPSII and PLCO studies). e Derived from the fixed effect meta-analysis of NJMU and NCI GWASs.
conducted mediation analysis (Figure 1 ). In our model, the total effect of the SNP on lung cancer risk was statistically significant (c = 0.302, SE = 0.048, P < 0.001). Both the effect of the SNP on the PC and the effect of the PC on lung cancer risk were also significant (a = 1.672, SE = 0.714, P = 0.019, b = 0.014, SE = 0.001, P < 0.001). Bootstrapping analysis suggested that smoking behavior was a mediator (indirect effect a*b = 0.023, SE = 0.010, P = 0.017). However, the direct effect of the SNP on lung cancer risk was still significant after adjustment for smoking behavior (c′ = 0.278, SE = 0.049, P < 0.001), suggesting that smoking behavior only partially explains the effect of rs6495304 on lung cancer risk (ab/c = 7.62%).
Variance explained by the independent variants in 15q25 region
On the basis of the two SNPs we identified and those reported in previous papers, we estimated the proportion of phenotypic variance explained using a liability threshold model with the population prevalence of 0.06% for lung cancer (1). We performed a heritability analysis using NJMU GWAS data and found that rs6495304 and rs74733525 could explain 2.88‰, whereas the 10 SNPs reported previously in this region could only explain 1.29‰ (Supplementary Table 7 , available at Carcinogenesis Online). In total, these twelve SNPs combined could explain 4.43‰ of the phenotypic variance. The two identified variants alone explain approximately 65.01% of the phenotypic variance attributable to genetic variation.
Discussion
Chromosome 15q25 is a bona fide locus associated with lung cancer risk and nicotine addiction that harbors the α5α3β4 family of nicotinic receptor genes. In this study, we provided a more comprehensive and accurate genetic landscape at 15q25 in Chinese individuals by using targeted resequencing technology. We identified two novel genetic variants (rs6495304 and rs74733525) that were associated with lung cancer risk and subsequently validated in large-scale GWASs within both Asian and European populations. We also presented data that the rs6495304 A allele may affect lung cancer development partially by pathways related to smoking behavior. In our analysis, rs6495304 and rs74733525 could explain approximately 65.01% of the phenotypic variance among the twelve SNPs for lung cancer in this region. Many previous studies of the effect of the 15q25 locus on lung cancer risk underscored the differences in LD structure between populations of European, Asian and African ancestry (34, 35) . This phenomenon is consistent with early population migration and evolution patterns (36) . Refining this region may help to identify association signals that are more likely to be population specific. The two variants identified in our study varied greatly in allelic frequencies among different ethnicities. Rs6495304 is common in Han Chinese in Beijing (CHB: MAF = 0.24) but rare in Centre d'Etude du Polymorphisme Humain Utah (CEU: MAF = 0.01) according to data from the 1000 Genomes Project. Rs74733525 is common in CHB (MAF = 0.08) and monomorphic in CEU.
In addition, studies have investigated the mediation effect of smoking behavior on the relationship between variants at the 15q25 region and lung cancer risk with little consensus as to the relative impact of the variants on the propensity for smoking or a direct carcinogenic effect. VanderWeele et al. (37) found no evidence that the CHRNA5-A3-B4 was associated with lung cancer, in interaction with smoking, whereas others found that this region indirectly acts on lung cancer risk through the mediation of smoking behavior (38) . In our study, we demonstrated that smoking was a mediator of the association between rs6495304 and lung cancer risk, which accounts for only 7.62% of the total effect of rs6495304 on lung cancer risk. We further confirmed the mediating effect by examining the effect among never-smokers (P = 0.08). The mediation analyses suggested that the association of rs6495304 with lung cancer risk is only marginally explained by smoking; thus, smoking behavior is necessary, but not sufficient, for the association between the SNP and lung cancer risk. Rs6495304 also showed a statistically significant multiplicative interaction with gender (P = 0.002, data not shown), indicating that gender is also important as the susceptibility to lung cancer; however, this might be confounded by the fact that 95% of patients among ever-smokers were men, suggesting that this association may be related to the sex difference in the propensity for smoking. Further, we performed stratification analyses by smoking status according to gender and only observed a stronger association in ever smokers of man (Supplementary  Table 5 , available at Carcinogenesis Online). Together, it was speculated that the interaction between rs6495304 and the gender was due to smoking factor.
Certain biologic hypotheses are consistent with this statistical evidence. Rs6495304, residing in the first intron of the AGPHD1 gene, demonstrates evidence of histone modifications consistent with promoter and enhancer activity in several cell lines. It has also been hypothesized that rs6495304 may alter the POU2F2 motif. POU2F2 expressed in mammalian neuronal cells (39) has been reported to be involved in important brain processes including neuronal and vascular development, neuronal survival, and basic cellular functions. In the expression quantitative trait loci analysis, we found that rs6495304 A allele was significantly associated with low mRNA expression of α3 nAChR. Nicotine could act on these receptors to release corticotropin-releasing factor in axon terminals of median eminence (40, 41) . Ainhoa et al. (42) indicated that corticotropin-releasing factor plays a critical role in stress-induced reinstatement of nicotine-seeking behavior. Thus, corticotropin-releasing factordependent stress produced by the change of CHRNA3 expression in the hypothalamus might reinstate a previously extinguished nicotine-seeking behavior.
In this study, we reported two novel SNPs on chromosome 15q25 previously undetected in Chinese population and highlighted the role of smoking behavior in mediating the link between rs6495304 and lung cancer risk. As sample size places a limitation on the ability to investigate rare variants, studies with a larger sample sizes are needed. Further functional studies are also required to confirm the roles of the newly discovered variants. acquired from smoking status, cigarettes/day, smoking duration and packyears) mediation model of the relationship between rs6495304 and lung cancer, adjusted by age and sex. In the model, the percentage of the effect mediated by smoking behavior is ~7.62% of the total effect of rs6495304 on lung cancer risk. *P < 0.05; **P < 0.001.
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